Heart failure may be associated with the onset of ischemic stroke with atrial fibrillation. A brain natriuretic peptide study

Journal of the Neurological Sciences

Volumn 281, Issue 1-2, 2009, Pages 55-57

  Shibazaki, Kensaku ^a   Kimura, Kazumi ^a   Okada, Yoko ^a   Iguchi, Yasuyuki ^a   Terasawa, Yuka ^a   Aoki, Junya ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Atrial fibrillation; Brain natriuretic peptide; Congestive heart failure

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ACUTE DISEASE; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CHRONIC DISEASE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OUTPATIENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

AGED; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; DIABETES COMPLICATIONS; FEMALE; HEART FAILURE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; LINEAR MODELS; LONGITUDINAL STUDIES; MALE; NATRIURETIC PEPTIDE, BRAIN; RISK FACTORS; SMOKING; STROKE;

EID: 67349164645     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2009.02.374     Document Type: Article

References (20)

1. Sudoh T., Kangawa K., Minamino N., and Matsuo H. A new natriuretic peptide in porcine brain. Nature 332 (1988) 78-81
2. Yamamoto K., Burnett Jr. J.C., Jougasaki M., Nishimura R.A., Bailey K.R., Saito Y., et al. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy. Hypertension 28 (1996) 988-994
3. McDonagh T.A., Robb S.D., Murdoch D.R., Morton J.J., Ford I., Morrison C.E., et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet 351 (1998) 9-13
4. Tsutamoto T., Wada A., Maeda K., Hisanaga T., Maeda Y., Fukai D., et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 96 (1997) 509-516
5. Nakagawa K., Yamaguchi T., Seida M., Yamada S., Imae S., Tanaka Y., et al. Plasma concentrations of brain natriuretic peptide in patients with acute ischemic stroke. Cerebrovasc Dis 19 (2005) 157-164
6. Makikallio A.M., Makikallio T.H., Korpelainen J.T., Vuolteenaho O., Tapanainen J.M., Ylitalo K., et al. Natriuretic peptides and mortality after stroke. Stroke 36 (2005) 1016-1020
7. Giannakoulas G., Hatzitolios A., Karvounis H., Koliakos G., Charitandi A., Dimitroulas T., et al. N-terminal pro-brain natriuretic peptide levels are elevated in patients with acute ischemic stroke. Angiology 56 (2005) 723-730
8. Yip H.K., Sun C.K., Chang L.T., Chen M.C., and Liou C.W. Time course and prognostic value of plasma levels of N-terminal pro-brain natriuretic peptide in patients after ischemic stroke. Circ J 70 (2006) 447-452
9. Jensen J.K., Mickley H., Bak S., Korsholm L., and Kristensen S.R. Serial measurements of N-terminal pro-brain natriuretic peptide after acute ischemic stroke. Cerebrovasc Dis 22 (2006) 439-444
10. Di Angelantonio E., De Castro S., Toni D., Sacchetti M.L., Biraschi F., Prencipe M., et al. Determinants of plasma levels of brain natriuretic peptide after acute ischemic stroke or TIA. J Neurol Sci 260 (2007) 139-142
11. Buckley M.G., Sethi D., Markandu N.D., Sagnella G.A., Singer D.R., and MacGregor G.A. Plasma concentrations and comparisons of brain natriuretic peptide and atrial natriuretic peptide in normal subjects, cardiac transplant recipients and patients with dialysis-independent or dialysis-dependent chronic renal failure. Clin Sci (Lond) 83 (1992) 437-444
12. Suzuki S., Yoshimura M., Nakayama M., Mizuno Y., Harada E., Ito T., et al. Plasma level of B-type natriuretic peptide as a prognostic marker after acute myocardial infarction: a long-term follow-up analysis. Circulation 110 (2004) 1387-1391
13. Lyden P., Brott T., Tilley B., Welch K.M., Mascha E.J., Levine S., et al. Improved reliability of the NIH stroke scale using video training. NINDS TPA Stroke Study Group. Stroke 25 (1994) 2220-2226
14. Sulter G., Steen C., and De Keyser J. Use of the Barthel index and modified Rankin scale in acute stroke trials. Stroke 30 (1999) 1538-1541
15. Wolf P.A., Abbott R.D., and Kannel W.B. Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med 147 (1987) 1561-1564
16. Lip G.Y., and Gibbs C.R. Does heart failure confer a hypercoagulable state? Virchow's triad revisited. J Am Coll Cardiol 33 (1999) 1424-1426
17. Komori T., Eguchi K., Tomizawa H., Ishikawa J., Hoshide S., Shimada K., et al. Factors associated with incident ischemic stroke in hospitalized heart failure patients: a pilot study. Hypertens Res 31 (2008) 289-294
18. Shimizu H., Murakami Y., Inoue S., Ohta Y., Nakamura K., Katoh H., et al. High plasma brain natriuretic polypeptide level as a marker of risk for thromboembolism in patients with nonvalvular atrial fibrillation. Stroke 33 (2002) 1005-1010
19. Maisel A.S., Krishnaswamy P., Nowak R.M., McCord J., Hollander J.E., Duc P., et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347 (2002) 161-167
20. Morrison L.K., Harrison A., Krishnaswamy P., Kazanegra R., Clopton P., and Maisel A. Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol 39 (2002) 202-209